secretory phospholipase A2
Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: A 21 year cohort
8
Differences between group X and group V secretory phospholipase A2 in lipolytic modification of lipoproteins
20
Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study
11
Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines
14
Secretory phospholipase-A2 and fatty acid composition in oral reactive lesions: a cross-sectional study
7
Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants
12
Endothelial protein C receptor associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2
12
Effect of polyunsaturated fatty acids on secretory phospholipase A2 type IIa in ectopic endometrial cells
8
Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat
11
Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti inflammatory agents in a rat model of antigen induced arthritis
11
Anti inflammatory effects of Polygonum minus (Huds) extract (Lineminus™) in in vitro enzyme assays and carrageenan induced paw edema
7
In vitro study of the PLA2 inhibition and antioxidant activities of Aloe vera leaf skin extracts
7
Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis
8
Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy
6
Subcellular characteristics of phospholipase A2 activity in the rat kidney Enhanced cytosolic, mitochondrial, and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion
10
Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma
10
Effect of α-lipoic Acid on Hemolytic Activity of Iranian Vipera Lebetina Venom
6
Regulated formation of eicosanoids
6
Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85 kD cytosolic phospholipase A2
10
In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei
16